Clinical Research Directory
Browse clinical research sites, groups, and studies.
STICH-3.0 International Trial Consortium
Sponsor: Vastra Gotaland Region
Summary
The primary objective of the STICH 3.0 Study is to determine whether CABG is superior to PCI in terms of all-cause mortality at 5 years in patients with severe CAD and iLVSD. Individual patient data from similar national RCTs independently powered for different efficacy endpoints will be pooled, harmonized, and analyzed. The primary endpoint is all-cause mortality.
Official title: The CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH) 3.0 International Trial Consortium
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2800
Start Date
2022-09-14
Completion Date
2029-09-14
Last Updated
2024-09-25
Healthy Volunteers
No
Conditions
Interventions
Percutaneous Coronary Intervention (PCI)
Alternative treatment
Locations (1)
Dep of Cardiology, Sahlgrenska University Hospital
Gothenburg, Sweden